SureChEMBL: A large-scale, chemically annotated patent document database

Nucleic Acids Research

Volumn 44, Issue D1, 2016, Pages D1220-D1228

  Papadatos, George ^a   Davies, Mark ^a,e   Dedman, Nathan ^a   Chambers, Jon ^a   Gaulton, Anna ^a   Siddle, James ^b,e   Koks, Richard ^b   Irvine, Sean A ^c   Pettersson, Joe ^d   Goncharoff, Nicko ^b   Hersey, Anne ^a   Overington, John P ^a,e  

^a EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^b Digital Science   (United Kingdom)

^c NetValue Ltd   (New Zealand)

^d MCKINSEY AND COMPANY   (United States)

^e Stratified Medical   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL DATABASE; CHEMICAL STRUCTURE; CONTENT ANALYSIS; DATA ANALYSIS; DATA EXTRACTION; DATA PROCESSING; MEDICINAL CHEMISTRY; PATENT; PRIORITY JOURNAL; SURECHEMBL DATABASE; CHEMISTRY; DATA MINING;

DRUG;

DATA MINING; DATABASES, CHEMICAL; PATENTS AS TOPIC; PHARMACEUTICAL PREPARATIONS;

EID: 84976888255     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv1253     Document Type: Article

References (26)

1. Downs, G.M. and Barnard, J.M. (2011) Chemical patent information systems. Wiley Interdiscip. Rev. Comput. Mol. Sci., 1, 727-741.
2. Akhondi, S.A., Klenner, A.G., Tyrchan, C., Manchala, A.K., Boppana, K., Lowe, D., Zimmermann, M., Jagarlapudi, S.A.R.P., Sayle, R., Kors, J.A. et al. (2014) Annotated chemical patent corpus: a gold standard for text mining. PLoS One, 9, e107477.
3. Bregonje, M. (2005) Patents: a unique source for scientific technical information in chemistry related industry? World Patent Inf., 27, 309-315.
4. Schneider, N., Lowe, D.M., Sayle, R.A. and Landrum, G.A. (2015) Development of a novel fingerprint for chemical reactions and its application to large-scale reaction classification and similarity. J. Chem. Inf. Model., 55, 39-53.
5. Kettle, J.G., Ward, R.A. and Griffen, E. (2010) Data-mining patent literature for novel chemical reagents for use in medicinal chemistry design. Medchemcomm, 1, 331-338.
6. Southan, C., Varkonyi, P., Boppana, K., Jagarlapudi, S.A.R.P. and Muresan, S. (2013) Tracking 20 years of compound-to-target output from literature and patents. PLoS One, 8, e77142.
7. Tyrchan, C., Boström, J., Giordanetto, F., Winter, J. and Muresan, S. (2012) Exploiting structural information in patent specifications for key compound prediction. J. Chem. Inf. Model., 52, 1480-1489.
8. Hattori, K., Wakabayashi, H. and Tamaki, K. (2008) Predicting key example compounds in competitors' patent applications using structural information alone. J. Chem. Inf. Model., 48, 135-142.
9. Benson, C.L. and Magee, C.L. (2015) Quantitative determination of technological improvement from patent data. PLoS One, 10, e0121635.
10. Heifets, A. and Jurisica, I. (2012) SCRIPDB: a portal for easy access to syntheses, chemicals and reactions in patents. Nucleic Acids Res., 40, D428-D433.
11. de Matos, P., Alcántara, R., Dekker, A., Ennis, M., Hastings, J., Haug, K., Spiteri, I., Turner, S. and Steinbeck, C. (2010) Chemical entities of biological interest: an update. Nucleic Acids Res., 38, D249-D254.
12. Degtyarenko, K., de Matos, P., Ennis, M., Hastings, J., Zbinden, M., McNaught, A., Alcántara, R., Darsow, M., Guedj, M. and Ashburner, M. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res., 36, D344-D350.
13. Wang, Y., Xiao, J., Suzek, T.O., Zhang, J., Wang, J. and Bryant, S.H. (2009) PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res., 37, W623-W633.
14. Chambers, J., Davies, M., Gaulton, A., Hersey, A., Velankar, S., Petryszak, R., Hastings, J., Bellis, L., McGlinchey, S. and Overington, J.P. (2013) UniChem: a unified chemical structure cross-referencing and identifier tracking system. J. Cheminform., 5, 3.
15. Chambers, J., Davies, M., Gaulton, A., Papadatos, G., Hersey, A. and Overington, J.P. (2014) UniChem: extension of InChI-based compound mapping to salt, connectivity and stereochemistry layers. J. Cheminform., 6, 43-53.
16. Brecher, J. (1999) Name = Struct: a practical approach to the sorry state of real-life chemical nomenclature. J. Chem. Inf. Comput. Sci., 39, 943-950.
17. Lowe, D.M., Corbett, P.T., Murray-Rust, P. and Glen, R.C. (2011) Chemical name to structure: OPSIN, an open source solution. J. Chem. Inf. Model., 51, 739-753.
18. Sayle, R., Xie, P.H. and Muresan, S. (2012) Improved chemical text mining of patents with infinite dictionaries and automatic spelling correction. J. Chem. Inf. Model., 52, 51-62.
19. Valko, A.T. and Johnson, A.P. (2009) CLiDE Pro: the latest generation of CLiDE, a tool for optical chemical structure recognition. J. Chem. Inf. Model., 49, 780-787.
20. Heller, S., McNaught, A., Stein, S., Tchekhovskoi, D. and Pletnev, I. (2013) InChI-the worldwide chemical structure identifier standard. J. Cheminform., 5, 7.
21. Weininger, D. (1988) SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci., 28, 31-36.
22. Bento, A.P., Gaulton, A., Hersey, A., Bellis, L.J., Chambers, J., Davies, M., Krüger, F.A., Light, Y., Mak, L., McGlinchey, S. et al. (2014) The ChEMBL bioactivity database: an update. Nucleic Acids Res., 42, D1083-D1090.
23. Gaulton, A., Bellis, L.J., Bento, A.P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B. et al. (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res., 40, D1100-D1107.
24. The Europe PMC Consortium. (2015) Europe PMC: a full-text literature database for the life sciences and platform for innovation. Nucleic Acids Res., 43, D1042-D1048.
25. Eisinger, D., Tsatsaronis, G., Bundschus, M., Wieneke, U. and Schroeder, M. (2013) Automated patent categorization and guided patent search using IPC as Inspired by MeSH and PubMed. J. Biomed. Semantics, 4, S3.
26. Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings1. Adv. Drug Deliv. Rev., 46, 3-26.